Page 2393 - Williams Hematology ( PDFDrive )

2364 Part XIII: Transfusion Medicine <CN>: Human Leukocyte and Platelet Antigens PB

106. Peterson JA, Nyree CE, Newman PJ, Aster RH: A site involving the “hybrid” and PSI 135. Pellitero S, Reverter JL, Tassies D, et al: Polymorphisms in platelet glycoproteins Ia and
homology domains of GPIIIa (beta 3-integrin subunit) is a common target for antibod- IIIa are associated with arterial thrombosis and carotid atherosclerosis in type 2 diabe-
ies associated with quinine-induced immune thrombocytopenia. Blood 101:937, 2003. tes. Thromb Haemost 103:630, 2008.
107. McFarland JG: Platelet and granulocyte antigens and antibodies, in Technical Manual 136. Curtis BR, McFarland JG: Human platelet antigens—2013. Vox Sang 106:93, 2014.
edited by JD Roback, p. 525. American Association of Blood Banks, Bethesda, MD, 137. Santoso S, Kroll H, Andrei-Selmer CL, et al: A naturally occurring LeuVal mutation
2008. in beta3-integrin impairs the HPA-1a epitope: the third allele of HPA-1. Transfusion
108. Warkentin TE, Smith JW: The alloimmune thrombocytopenic syndromes. Transfus 46:790, 2006.
Med Rev 11:296, 1997. 138. Peterson JA, Gitter M, Bougie DW, et al: Low-frequency human platelet antigens as
109. West KA, Anderson DR, McAlister VC, et al: Alloimmune thrombocytopenia after triggers for neonatal alloimmune thrombocytopenia. Transfusion 54:1286, 2014.
organ transplantation. N Engl J Med 341:1504, 1999. 139. Sheridan D, Carter C, Kelton JG: A diagnostic test for heparin-induced thrombocy-
110. Li C, Pasquale DN, Roth GJ: Bernard-Soulier syndrome with severe bleeding: Absent topenia. Blood 67:27, 1986.
platelet glycoprotein Ib alpha due to a homozygous one-base deletion. Thromb Haemost 140. Rachel JM, Summers TC, Sinor LT, Plapp FV: Use of a solid phase red blood cell adher-
76:670, 1996. ence method for pretransfusion platelet compatibility testing. Am J Clin Pathol 90:63,
111. Conte R, Cirillo D, Ricci F, et al: Platelet transfusion in a patient affected by 1988.
Glanzmann’s thrombasthenia with antibodies against GPIIb-IIIa. Haematologica 82:73, 141. Davoren A, Bussel J, Curtis BR, et al: Prospective evaluation of a new platelet glycopro-
1997. tein (GP)-specific assay (PakAuto) in the diagnosis of autoimmune thrombocytopenia
112. Skouri H, Bettaieb A, Fromont P, et al: Platelet and granulocyte alloimmunisation in (AITP). Am J Hematol 78:193, 2005.
multitransfused Tunisian patients. Eur J Haematol 75:248, 2005. 142. Kiefel V, Santoso S, Weisheit M, Mueller-Eckhardt C: Monoclonal antibody-specific
113. Kashyap R, Kriplani A, Saxena R, et al: Pregnancy in a patient of Glanzmann’s throm- immobilization of platelet antigens (MAIPA): A new tool for the identification of
basthenia with antiplatelet antibodies. J Obstet Gynaecol Res 23:247, 1997. platelet-reactive antibodies. Blood 70:1722, 1987.
114. Greenwalt DE, Lipsky RH, Ockenhouse CF, et al: Membrane glycoprotein CD36: A 143. Visentin GP, Wolfmeyer K, Newman PJ, Aster RH: Detection of drug-dependent,
review of its roles in adherence, signal transduction, and transfusion medicine. Blood platelet-reactive antibodies by antigen-capture ELISA and flow cytometry. Transfusion
80:1105, 1992. 30:694, 1990.
115. Yanai H, Chiba H, Morimoto M, et al: Human CD36 deficiency is associated with ele- 144. Panzer S: Report on the Tenth International Platelet Genotyping and Serology
vation in low-density lipoprotein-cholesterol. Am J Med Genet 93:299, 2000. Workshop on behalf of the International Society of Blood Transfusion. Vox Sang 80:72,
116. Yanai H, Chiba H, Fujiwara H, et al: Phenotype-genotype correlation in CD36 defi- 2001.
ciency types I and II. Thromb Haemost 84:436, 2000. 145. Simsek S, Faber NM, Bleeker PM, et al: Determination of human platelet antigen fre-
117. Ikeda H, Mitani T, Ohnuma M, et al: A new platelet-specific antigen, Naka, involved in quencies in the Dutch population by immunophenotyping and DNA (allele-specific
the refractoriness of HLA-matched platelet transfusion. Vox Sang 57:213, 1989. restriction enzyme) analysis. Blood 81:835, 1993.
118. Curtis BR, Aster RH: Incidence of the Nak(a)-negative platelet phenotype in African 146. McFarland JG, Aster RH, Bussel JB, et al: Prenatal diagnosis of neonatal alloimmune
Americans is similar to that of Asians. Transfusion 36:331, 1996. thrombocytopenia using allele-specific oligonucleotide probes. Blood 78:2276, 1991.
119. Aitman TJ, Cooper LD, Norsworthy PJ, et al: Malaria susceptibility and CD36 muta- 147. Curtis B, McFarland J: Detection and identification of platelet antibodies and antigens
tion. Nature 405:1015, 2000. in the clinical laboratory. Immunohematology 25:125, 2009.
120. Kajeguka D, Mwanziva C, Daou M, et al: CD36 c.1264 T>G null mutation impairs acqui- 148. Curtis BR: Genotyping for human platelet alloantigen polymorphisms: applications in
sition of IgG antibodies to Plasmodium falciparum MSP1 antigen and is associated with the diagnosis of alloimmune platelet disorders. Semin Thromb Hemost 34:539, 2008.
19
higher malaria incidences in Tanzanian children. Scand J Immunol 75:355, 2012. 149. Skogen B, Bellissimo DB, Hessner MJ, et al: Rapid determination of platelet alloanti-
121. Chilongola J, Balthazary S, Mpina M, et al: CD36 deficiency protects against malar- gen genotypes by polymerase chain reaction using allele-specific primers. Transfusion
ial anaemia in children by reducing Plasmodium falciparum-infected red blood cell 34:955, 1994.
adherence to vascular endothelium. Trop Med Int Health 14:810, 2009. 150. Hurd CM, Cavanagh G, Schuh A, et al: Genotyping for platelet-specific antigens: tech-
122. Bierling P, Godeau B, Fromont P, et al: Posttransfusion purpura-like syndrome associ- niques for the detection of single nucleotide polymorphisms. Vox Sang 83:1, 2002.
ated with CD36 (Naka) isoimmunization. Transfusion 35:777, 1995. 151. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmuniza-
123. Kankirawatana S, Kupatawintu P, Juji T, et al: Neonatal alloimmune thrombocytopenia tion and refractoriness to platelet transfusions. The Trial to Reduce Alloimmunization
due to anti-Nak(a). Transfusion 41:375, 2001. to Platelets Study Group. N Engl J Med 337:1861, 1997.
124. Curtis BR, Ali S, Glazier AM, et al: Isoimmunization against CD36 (glycoprotein IV): 152. Taaning E, Simonsen AC, Hjelms E, et al: Platelet alloimmunization after transfusion. A
description of four cases of neonatal isoimmune thrombocytopenia and brief review of prospective study in 117 heart surgery patients. Vox Sang 72:238, 1997.
the literature. Transfusion 42:1173, 2002. 153. Kiefel V, Konig C, Kroll H, Santoso S: Platelet alloantibodies in transfused patients.
125. Saw CL, Szykoluk H, Curtis BR, et al: Two cases of platelet transfusion refractoriness Transfusion 41:766, 2001.
associated with anti-CD36. Transfusion 50:2638, 2010. 154. Langenscheidt F, Kiefel V, Santoso S, Mueller-Eckhardt C: Platelet transfusion refrac-
126. Newman PJ, Valentin N: Human platelet alloantigens: recent findings, new perspec- toriness associated with two rare platelet-specific alloantibodies (anti-Baka and anti-
tives. Thromb Haemost 74:234, 1995. PlA2) and multiple HLA antibodies. Transfusion 28:597, 1988.
127. European Molecular Biology Laboratory EBI. 2014. http://www.ebi.ac.uk/ipd/hpa/ 155. Kekomaki S, Volin L, Koistinen P, et al: Successful treatment of platelet transfusion
freqs_1.html (last accessed August, 2015). refractoriness: the use of platelet transfusions matched for both human leucocyte anti-
128. Lyman S, Aster RH, Visentin GP, Newman PJ: Polymorphism of human platelet gens (HLA) and human platelet alloantigens (HPA) in alloimmunized patients with
membrane glycoprotein IIb associated with the Baka/Bakb alloantigen system. Blood leukaemia. Eur J Haematol 60:112, 1998.
75:2343, 1990. 156. Verran J, Grey D, Bennett J, et al: HPA-1, 3, 5 genotyping to establish a typed platelet
129. Harrison CR, Curtis BR, McFarland JG, et al: Severe neonatal alloimmune thrombo- donor panel. Pathology 32:89, 2000.
cytopenia caused by antibodies to human platelet antigen 3a (Baka) detectable only in 157. Godeau B, Fromont P, Seror T, et al: Platelet alloimmunization after multiple transfu-
whole platelet assays. Transfusion 43:1398, 2003. sions: a prospective study of 50 patients. Br J Haematol 81:395, 1992.
130. Bray PF: Integrin polymorphisms as risk factors for thrombosis. Thromb Haemost 158. Novotny VM: Prevention and management of platelet transfusion refractoriness. Vox
82:337, 1999. Sang 76:1, 1999.
131. Goldschmidt-Clermont PJ, Roos CM, Cooke GE: Platelet PlA2 polymorphism and 159. Meenaghan M, Judson PA, Yousaf K, et al: Antibodies to platelet glycoprotein V in
thromboembolic events: from inherited risk to pharmacogenetics. J Thromb Throm- polytransfused patients with haematological disease. Vox Sang 64:167, 1993.
bolysis 8:89, 1999. 160. Wang R, Furihata K, McFarland JG, et al: An amino acid polymorphism within the
132. Harris K, Nguyen P, Van Cott EM: Platelet PlA2 Polymorphism and the risk for throm- RGD binding domain of platelet membrane glycoprotein IIIa is responsible for the for-
bosis in heparin-induced thrombocytopenia. Am J Clin Pathol 129:282, 2008. mation of the Pena/Penb alloantigen system. J Clin Invest 90:2038, 1992.
133. Ollikainen E, Mikkelsson J, Perola M, et al: Platelet membrane collagen receptor glyco- 161. Furihata K, Nugent DJ, Bissonette A, et al: On the association of the platelet-specific
protein VI polymorphism is associated with coronary thrombosis and fatal myocardial alloantigen, Pena, with glycoprotein IIIa. Evidence for heterogeneity of glycoprotein
infarction in middle-aged men. Atherosclerosis 176:95, 2004. IIIa. J Clin Invest 80:1624, 1987.
134. Martinelli N, Trabetti E, Pinotti M, et al: Combined effect of hemostatic gene poly- 162. Glade-Bender J, McFarland JG, Kaplan C, et al: Anti-HPA-3A induces severe neonatal
morphisms and the risk of myocardial infarction in patients with advanced coronary alloimmune thrombocytopenia. J Pediatr 138:862, 2001.
atherosclerosis. PLoS One 3:e1523, 2008. 163. Santoso S: Human platelet alloantigens. Transfus Apher Sci 28:227, 2003.

Kaushansky_chapter 137_p2353-2364.indd 2364 9/21/15 3:50 PM